2026
- Feb 12, 2026 Notice Regarding Revision of Financial Forecasts
- Feb 12, 2026 Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
- Jan 27, 2026 Notice Regarding the Launch of "Middle Conditioning Program," a New Service Under the Healthcare Brand "WELLMILL"
- Jan 27, 2026 Notice Regarding the Launch of "StemEdit," a Clinical-Grade Gene Editing Service
- Jan 26, 2026 Notice Regarding the Launch of "Genetic Age Measurement Kit," a New Service to Scientifically Visualize Biological Age